首页> 外文期刊>American journal of medical genetics, Part A >Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene
【24h】

Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene

机译:GNPTAB基因中具有纯合错义突变的II型粘液脂血症α/β

获取原文
获取原文并翻译 | 示例
           

摘要

The uridine diphosphate (UDP)-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (termed GlcNAc-1-phosphotransferase; EC 2.7.8.17) is a Golgi-resident 540-kDa hexameric transmembrane enzyme composed by three subunits, (X2P2Y2! which catalyzes the first step in the formation of the M6P recognition marker on lysosomal enzymes. This marker is essential for the proper recognition of newly synthesized lysosomal hydrolases by specific M6P receptors, required for lysosomal targeting. The receptor-enzyme complexes are selectively transported and, upon arrival in the endosomal/lysosomal compartment, dissociate due to the typical low pH. Lysosomal proteins are then delivered to the lysosomes, while the M6P receptors return to the Golgi apparatus for subsequent rounds of [Braulke and Bonifacino, 2009] transport. Impairments in the formation of the M6P recognition marker due to defective GlcNAc-1 -phosphotransferase are the basis of two rare lysosomal storage disorders: Mucolipidosis II (ML II) and Mucolipidosis III (ML III).
机译:尿苷二磷酸(UDP)-N-乙酰氨基葡萄糖:溶酶体酶N-乙酰氨基葡萄糖-1-磷酸转移酶(称为GlcNAc-1-磷酸转移酶; EC 2.7.8.17)是由三个亚基组成的高尔基体540kDa六聚体跨膜酶,( X2P2Y2!催化在溶酶体酶上形成M6P识别标记的第一步,该标记对于溶酶体靶向所需的特定M6P受体正确识别新合成的溶酶体水解酶是必不可少的。然后,由于典型的低pH值,到达内体/溶酶体区室时解离,然后溶酶体蛋白被递送至溶酶体,而M6P受体返回高尔基体,用于随后的[Braulke and Bonifacino,2009]转运。由于缺陷的GlcNAc-1-磷酸转移酶而导致的M6P识别标记形成障碍是两种罕见的溶酶体贮积病的基础:血脂异常II(ML II)和血脂异常III(ML III)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号